4. STOCK OPTION PLAN AND STOCK-BASED COMPENSATION
|3 Months Ended|
Mar. 31, 2014
|Notes to Financial Statements|
|NOTE 4 - STOCK OPTION PLAN AND STOCK-BASED COMPENSATION||
During the year ended December 31, 2010, the Company adopted a stock option plan entitled The 2010 Stock Plan (2010 Plan) under which the Company may grant options to purchase up to 5,000,000 shares of common stock. On September 7, 2013, the 2010 plan was amended to increase the number of shares of common stock issuable under the 2010 Plan to 7,500,000. As of March 31, 2014 and December 31, 2013, there were 1,278,400 and 578,400 options outstanding under the 2010 Plan, respectively.
During the year ended December 31, 2011, the Company adopted a non-qualified stock option plan entitled 2011 Non-Qualified Stock Plan (2011 Plan) under which the Company may grant options to purchase 2,100,000 shares of common stock. In December 2012, the 2011 Plan was amended to increase the number of shares of common stock issuable under the 2011 Plan to 12,000,000 shares. During the period ended March 31, 2013, the 2011 Plan was amended to increase the number of shares of common stock issuable under the 2011 Plan to 17,500,000. As of March 31, 2014 and December 31, 2013, there were 5,543,720 and 5,163,000 options outstanding under the 2011 Plan, respectively.
Under the terms of the stock plans, the Board of Directors shall specify the exercise price and vesting period of each stock option on the grant date. Vesting of the options is typically one to four years and the options typically expire in five to ten years.
In February 2014 the Board of Directors approved a grant of non-qualified stock options to the independent directors of the Company to purchase an aggregate of 279,000 shares of the Companys common stock. The options were allocated among the directors based on service in, and chairmanship of the Companys committees and service as lead independent director. The options vest as of December 31, 2014, provided that the directors remain directors on that date and have attended at least 75% of the scheduled meetings of the Board and the committees on which such directors serve during the 2014 calendar year. In addition, during the period ended March 31, 2014, the Company granted incentive stock options to members of management, non-management, and directors of the Company to purchase an aggregate of 800,000 shares of the Companys common stock at exercises prices ranging from $0.69 to $1.21 per share, of which 450,000 of these options vested immediately. The remaining unvested stock options vest quarterly over a period of one to four years. In addition, the Company granted, to consultants of the Company, non-qualified stock options to purchase up to 140,000 shares of the Companys common stock at exercise prices ranging from $1.00 to $1.21 per share vesting over a one to two year period.
The fair value of stock options granted or revalued for three months ended March 31, 2014 and 2013 was calculated with the following assumptions:
The weighted-average fair value of stock options granted during the three months ended March 31, 2014 and 2013, under the Black-Scholes option pricing model was $0.83 and $0.25 per share, respectively.
The Company recognized $503,772 and $192,165 of stock-based compensation costs in the accompanying statement of operations for the three months ended March 31, 2014 and 2013, respectively. As of March 31, 2014, there was approximately $584,000 of unrecognized compensation expense related to non-vested stock option awards that is expected to be recognized over a weighted average period of 2.25 years.
The following table summarizes the Companys stock option activity during the three months ended March 31, 2014:
During the three months ended March 31, 2014, the Company received a notice of cashless stock options exercise in which the holder elected to exercise 133,280 common stock options. The stock options which were exercised had an exercise price of $0.57 per share. Based upon the Companys stock price on the date of exercise, as well as the cashless exercise formula, 79,016 shares were issued to the holder during the period ended March 31, 2014 with the remaining 54,264 options forfeited. In addition, the Company also received $500 for stock options exercised. There were no stock options exercises in the three months ended March 31, 2013.
The following table summarizes information about stock options that are vested or expected to vest at March 31, 2014:
The weighted-average remaining contractual life for stock options exercisable at March 31, 2014 is 4.00 years. At March 31, 2014, the Company has 11,956,280 and 6,221,600 options available for grant under the 2011 Plan and 2010 Plan, respectively. The intrinsic value for fully vested, exercisable options was $1,870,500 and $5,061,256 at March 31, 2014 and December 31, 2013, respectively. The aggregate intrinsic value of options exercised during the three months ended March 31, 2014 was $71,083. No actual tax benefit was realized from stock option exercises during these periods.
The following table sets forth the status of the Companys non-vested stock options as of March 31, 2014:
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
Reference 1: http://www.xbrl.org/2003/role/presentationRef